Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
O1-pentyl-mannose is a synthetic glycoside derivative of mannose in which a pentyl group is attached to the anomeric oxygen of the mannopyranoside ring. It belongs to the class of fatty acyl glycosides of mono- and disaccharides. The compound has a molecular formula C11H22O6 and a molecular weight of approximately 250.29 g/mol[1][2][6]. Its structure features multiple hydroxyl groups and a pentyl substituent that influences its solubility and reactivity[6]. O1-pentyl-mannose is primarily used as an experimental research tool for studying carbohydrate-protein interactions—particularly with lectins such as cyanovirin-N—and for exploring how mannose derivatives affect cellular functions and metabolic pathways[1][6]. There are no approved therapeutic indications or clinical uses for this compound; it remains at the experimental stage.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on O1-pentyl-mannose.